Gambaran Penggunaan Obat Antihipertensi pada Pasien Geriatri Rawat Jalan dengan Penyakit Kardiovaskular
Abstract
In Indonesia, in 2023 the geriatric population will reach 10.48% of the total population of Indonesia. The risk of cardiovascular disease increases with age. One of the pharmacological therapies used to treat cardiovascular disease is the use of antihypertensive drugs. The aim of administering antihypertensive drugs is to achieve the expected blood pressure target thereby reducing the risk of disease complications and death. The importance of using antihypertensive drugs in geriatric patients is very important to ensure the effectiveness and safety of treatment. this research aims to determine the pattern of antihypertensive drugs used in geriatric outpatients with cardiovascular disease. The data collection process was carried out for 2 months prospectively using data collection sheets at the Sehat Bersama 1 Pharmacy, Bengkulu City. The sample in this study were patients who met the study inclusion criteria. Data were obtained from prescriptions and patient medication records. Data taken includes age, diagnosis, and type of medication used. The research results showed that there were 90 geriatric patients who met the inclusion criteria. Most of the patients received a combination of antihypertensive drug classes, 63 patients. The class of drugs most commonly found is Calcium Channel Blocker (CCB) class, namely amlodipine (25.0%), followed by Angiotensin Receptor Blocker (ARB) drug, namely Candesartan (21.4%), and Beta Blocker (BB), namely bisoprolol (15.9%). This research shown that most geriatric patients need combination therapy of antihypertensive drug and most of patient using Amlodipine, Candesartan and Bisoprolol. It’s important to monitor the side effect and effectivity of this antihypertensive drugs especially in geriatric .
Keywords
Full Text:
PDFReferences
N. K. W. Facc, F. I. M. Facc, and R. A. O. Facc, ‘Cardiovascular disease in the elderly’, Cardiovasc. Dis. Elder., vol. 10.
R. T. Desty and S. I. N. Rohmah, ‘Peningkatan Pengetahuan Faktor Risiko Kardiovaskular pada Lansia’, PEKAT J. Pengabdi. Kpd. Masy., vol. 3, no. 1, Art. no. 1, May 2024, doi: 10.37148/pekat.v3i1.35.
R. A. E. P. Dewi and M. Syaifulloh, ‘Prediksi Resiko Penyakit Kardiovaskular Pada Lansia Yang Mengonsumsi Caffeine’, Indones. J. Biomed. Sci. Health, vol. 2, no. 2, Art. no. 2, Jan. 2023, doi: 10.31331/ijbsh.v2i2.2408.
M. D. A. Shas, S. Adiana, and A. U. H. Rochjana, ‘Gambaran Penggunaan Antihipertensi Pada Pasien BPJS Poliklinik Penyakit Dalam Rumah Sakit X Periode Mei–Juli 2023’, Indones. J. Health Sci., vol. 4, no. 4, Art. no. 4, Jun. 2024, doi: 10.54957/ijhs.v4i4.931.
W. Widyastuti, N. Noviar, and M. Putra, ‘GAMBARAN PENGGUNAAN OBAT ANTIHIPERTENSI DI BANGSAL PENYAKIT DALAM RSUD DR. ACHMAD DARWIS’, SITAWA J. Farm. Sains Dan Obat Tradis., vol. 1, no. 2, Art. no. 2, Jul. 2022, doi: 10.62018/sitawa.v1i2.10.
Z. Gao, Z. Chen, A. Sun, and X. Deng, ‘Gender differences in cardiovascular disease’, Med. Nov. Technol. Devices, vol. 4, p. 100025, Dec. 2019, doi: 10.1016/j.medntd.2019.100025.
Ario Wahid Sauma, Isyeu Sriagustini, Sinta Fitriani, Wuri Ratna Hidayani, and Leni M. Malabanan, ‘The Analysis of Factors Influencing Hypertension on Elderly: A Literature Study’, J. Public Health Sci., vol. 1, no. 01, pp. 16–29, Aug. 2022, doi: 10.56741/jphs.v1i01.45.
S. H. Bots, S. A. E. Peters, and M. Woodward, ‘Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010’, BMJ Glob. Health, vol. 2, no. 2, p. e000298, Mar. 2017, doi: 10.1136/bmjgh-2017-000298.
S. S. Alyami, A. Algharbi, and S. Alsuwaidan, ‘Characteristics of Associated Diseases in Older Patients with Cardiovascular Disease’, Adv. Aging Res., vol. 11, no. 6, Art. no. 6, Nov. 2022, doi: 10.4236/aar.2022.116011.
B. Vegada, A. Shah, D. Shah, K. Mogal, H. Santoki, and R. Joshi, ‘Polypharmacy and potential drug-drug interactions among geriatric patients’, Natl. J. Physiol. Pharm. Pharmacol., no. 0, p. 1, 2020, doi: 10.5455/njppp.2020.10.02055202017032020.
E. Wani and C. R. Lestari, ‘Gambaran Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Lanjut Usia 60-70 Tahun di UPTD. Puskesmas Lamasi Timur’, Indones. J. Biomed. Sci. Health, vol. 1, no. 1, Art. no. 1, Sep. 2021, doi: 10.31331/ijbsh.v1i1.1838.
S. Sayyidah, I. Indiana, H. M. Hasan, and A. I. Ulumudin, ‘POLA PERESEPAN OBAT ANTIHIPERTENSI PADA PASIEN RAWAT INAP DI RUMAH SAKIT X PERIODE JANUARI - MARET 2020’, Pros. SENANTIAS Semin. Nas. Has. Penelit. Dan Pengabdi. Kpd. Masy., vol. 1, no. 1, Art. no. 1, 2020.
D. Hastuti, ‘Profil Peresepan Obat Antihipertensi Pada Pasien Hipertensi di Apotek Afina’, Maj. Farm., vol. 18, no. 3, Art. no. 3, Oct. 2022, doi: 10.22146/farmaseutik.v18i3.77737.
J. Ma, X.-Y. Wang, Z.-D. Hu, Z.-R. Zhou, P. Schoenhagen, and H. Wang, ‘Meta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy’, J. Thorac. Dis., vol. 7, no. 12, Dec. 2015, doi: 10.3978/j.issn.2072-1439.2015.12.39.
H. M. A. Abraham, C. M. White, and W. B. White, ‘The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases’, Drug Saf., vol. 38, no. 1, p. 33, Jan. 2015, doi: 10.1007/s40264-014-0239-7.
DOI: https://doi.org/10.37311/ijpe.v4i3.28131
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Reza Rahmawati
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.